"use client";
import React from 'react';
import { HeroVariationB, ClinicalDeepDive, InsuranceBreakdown, PatientArchetype, LocalTransitPain, CostComparisonTable, InteractiveFAQ, StateLegalFramework, DeliveryGridMap, FinalCTA } from './location-modules.jsx';

export function LocationBoston() {
  return (
    <div style={{ background: '#FBF8F3', overflow: 'hidden' }}>

      <HeroVariationB
        stateName="Massachusetts"
        cityName="Boston"
        headline="Clinical GLP-1 Weight Loss in <span style='color: #2ECC71'>Boston</span>"
        subheadline="Boston is the biomedical capital of the world. Kendall Square literally invents the future of pharmacology. And yet, the researchers designing the next generation of peptide therapeutics face the exact same insurance denials and 4-month waitlists as everyone else. Compounded Semaglutide, delivered from Somerville to the South Shore."
        dataPoint1="The Longwood Medical Area contains the highest concentration of medical expertise on the planet, but new-patient endocrinology wait times at MGH and Brigham still average 12 to 16 weeks."
        dataPoint2="Telehealth FX bypasses the academic medical center bottleneck, providing immediate, clinical-grade metabolic care evaluated by licensed physicians."
      />

      <ClinicalDeepDive
        title="The Kendall Square Paradox"
        paragraphs={[
          "Boston presents the ultimate irony in American healthcare. Between the biotech cluster in Kendall Square (Cambridge) and the academic medical monoliths in the Longwood Medical Area, Greater Boston is the undisputed global epicenter of biomedical research. The scientists here map the genome, design novel receptor agonists, and run the clinical trials that prove these medications work. Yet, when those same scientists, hospital administrators, and academic staff try to access GLP-1 weight management therapies for themselves, they crash into the exact same bureaucratic wall as the rest of the country.",
          "This is the Kendall Square Paradox: geographic proximity to medical innovation does not equal access to it. The health plans administered by Boston's universities, hospitals, and even its biotech firms rely on the same Pharmacy Benefit Managers (PBMs) that dictate care nationally. The result is a highly educated, medically literate workforce that understands exactly how GLP-1 receptor agonists function at the molecular level, but who are denied access because their BMI is 29 instead of 30, or because they haven't spent six months documenting a failed attempt at behavioral weight loss.",
          "The metabolic environment in Boston is shaped by two powerful forces: academic/professional stress and New England winters. Boston's economy runs on intellectual capital—higher education, tech, finance, and biotech. It is a culture of extreme credentialism and intense, cortisol-driving professional pressure. This chronic stress environment directly impairs insulin sensitivity, independent of diet.",
          "When winter sets in—bringing four months of freezing temperatures, early sunsets (often before 4:30 PM), and the resulting Seasonal Affective Disorder—the physiological drive for simple carbohydrates surges. And New England culture provides the perfect delivery mechanism: the ubiquitous Dunkin' run. The Boston metabolic reality often looks like a post-doc researcher working a 12-hour day in a windowless lab, surviving on cortisol and two large iced coffees with caramel swirl (roughly 500 calories and 80g of sugar each).",
          "GLP-1 medications correct the hormonal dysregulation that this high-stress, low-sunlight, carb-heavy environment produces. They restore the incretin signaling that allows the body to regulate glucose and appetite. For Boston's professional class, these medications aren't a shortcut—they are the applied science that their own city helped develop."
        ]}
        citations={[
          "Boston Public Health Commission. (2025). <em>Health of Boston Report: Chronic Disease and Metabolic Indicators in Suffolk County</em>.",
          "Harvard T.H. Chan School of Public Health. (2024). <em>Occupational Stress, Circadian Disruption, and Insulin Resistance in Academic and Research Populations</em>.",
          "Massachusetts Health Policy Commission. (2024). <em>Specialty Pharmaceutical Access and Prior Authorization Delays in Commercial Health Plans</em>."
        ]}
      />

      <PatientArchetype
        archetype="The Cambridge Biotech Bench Scientist"
        quote="I work in a lab three blocks from Moderna. My PhD is in molecular biology. I spent three years studying peptide degradation pathways. When my Blue Cross plan denied my Wegovy prescription because I didn't have 'documented failure of a comprehensive lifestyle intervention,' I almost laughed. I know the clinical data better than the insurance adjuster who denied the claim. The system isn't broken—it's functioning exactly as the PBMs designed it to."
        details="<strong>Patient Profile:</strong> Elena, 34, Senior Scientist at a mid-size biotech firm, Kendall Square (Cambridge).<br/><br/><strong>The Challenge:</strong> Elena understands the pharmacokinetics of Semaglutide better than most practicing physicians. But biological expertise does not grant formulary access. Working 60-hour weeks in a high-pressure research environment, her cortisol levels were chronically elevated, and she had slowly accumulated 40 pounds of stress-driven weight. Her employer's health plan classified GLP-1 weight management as a specialty tier exclusion unless accompanied by Type 2 Diabetes. The irony was suffocating: she was literally developing novel therapeutics for metabolic disease during the day, while being denied access to existing therapeutics for her own metabolic disease by her insurance.<br/><br/><strong>The Intervention:</strong> Elena completed the Telehealth FX intake from her Somerville apartment. A Massachusetts-licensed physician reviewed her profile asynchronously. As a scientist, she appreciated the clinical rigor of the Telehealth FX model and the transparency of the 503A compounding pharmacy sourcing. Compounded Semaglutide was prescribed and delivered overnight. She bypassed the PBM bureaucracy entirely."
      />

      <CostComparisonTable
        title="What Weight Loss Actually Costs in Boston"
        localCompetitors={[
          { name: "Back Bay / Beacon Hill Concierge", cost: "$900 - $1,500 / mo", consult: "Mandatory In-Person + Full Panel", access: "Branded Only / VIP Access" },
          { name: "Seaport / South End Aesthetic Clinics", cost: "$500 - $900 / mo", consult: "Monthly Membership + Consult", access: "Variable Compounding + B12" },
          { name: "MGH / Brigham Endocrinology", cost: "$150 Copay + Rx", consult: "12-16 Week New Patient Wait", access: "Formulary Restrictions / Prior Auth" },
          { name: "Beth Israel Lahey PCP", cost: "$50 Copay", consult: "6-10 Week Wait", access: "Step Therapy / Pharmacy Backorder" }
        ]}
        telehealthPrice="From $146 / mo"
      />

      <InsuranceBreakdown
        title="The Higher Ed and Hospital Access Gap"
        text="Boston's largest employers are its universities and its hospital systems (known locally as 'meds and eds'). These institutions offer comprehensive benefits, but they apply the same aggressive utilization management for GLP-1s as any corporate employer."
        employers={[
          { name: "Mass General Brigham (MGB) / Beth Israel Lahey", detail: "The massive health systems that dominate Boston employ tens of thousands of clinical and administrative staff. Their employee health plans typically enforce strict BMI thresholds (often 35+) and mandate participation in employer-sponsored behavioral weight loss programs before considering GLP-1 authorization. The nurses and techs treating metabolic disease face immense barriers to accessing the treatment themselves." },
          { name: "Harvard / MIT / BU (Higher Education)", detail: "Boston's academic institutions offer excellent health plans, often administered by Blue Cross Blue Shield of Massachusetts or Harvard Pilgrim. However, these plans frequently place GLP-1 weight management on restricted tiers, requiring exhaustive Step Therapy documentation. Post-docs and junior faculty—who suffer from intense chronic stress and poor sleep—often find the administrative burden of securing authorization insurmountable." },
          { name: "The Biotech/Pharma Sector (Kendall Square/Waltham)", detail: "Even at the companies that research and manufacture pharmaceuticals, employee health plans are typically managed by third-party PBMs (like CVS Caremark or Express Scripts) that apply national, restrictive formulary guidelines. Working in biotech does not exempt you from the PBM's prior authorization maze." }
        ]}
      />

      <LocalTransitPain
        title="Bypass the MBTA Dysfunction & Longwood Waitlists"
        transitText="Getting around Boston is a daily test of endurance. The MBTA (the 'T') is plagued by chronic delays, slow zones, and weekend line closures. If you decide to drive, you face the nightmare of Storrow Drive, the perpetual congestion on the Mass Pike (I-90), or the Southeast Expressway crawl. Traveling from Somerville to a specialist appointment in the Longwood Medical Area via the Green Line can easily take an hour each way for a 15-minute consult."
        hospitalText="Boston boasts the greatest concentration of top-tier hospitals in the world: <strong>Massachusetts General Hospital (MGH)</strong>, <strong>Brigham and Women's</strong>, <strong>Beth Israel Deaconess</strong>, and <strong>Boston Medical Center</strong>. But this global reputation is precisely the problem for local access. People fly from across the globe to see Boston's specialists. As a result, a local resident trying to book a new-patient endocrinology or weight management appointment at MGH faces a 12- to 16-week waitlist. Your local <strong>CVS</strong> (headquartered just south in Woonsocket) or <strong>Walgreens</strong> pharmacy has branded Wegovy on the exact same national backorder."
      />

      <InteractiveFAQ
        faqs={[
          { q: "I work at MGH. Is it a conflict of interest to use Telehealth FX?", a: "No. Telehealth FX is an independent, private medical platform with no affiliation to Mass General Brigham, any other hospital system, or any insurance company. Your medical record with us is entirely private and does not interact with your employer's occupational health or employee health plan." },
          { q: "I have a PhD in a biological science. Can I skip the clinical intake?", a: "No. While we respect your scientific expertise, establishing a legal physician-patient relationship and prescribing medication requires a formal clinical evaluation by a licensed physician. The intake is brief, asynchronous, and designed to capture the specific medical history required for safe prescribing." },
          { q: "Do you deliver to the suburbs or just the city proper?", a: "We deliver to all residential and commercial addresses in Greater Boston and throughout Massachusetts. This includes Cambridge, Somerville, Brookline, Newton, the Route 128 tech corridor (Waltham, Burlington), the North Shore, the South Shore, and MetroWest." },
          { q: "How does Telehealth FX bypass the MGH waitlist?", a: "We do not use the traditional, centralized academic medical center model. Our network of state-licensed physicians reviews intakes asynchronously through our specialized platform, eliminating the need for brick-and-mortar waiting rooms, scheduling coordinators, and months-long appointment backlogs." },
          { q: "Is the compounded Semaglutide you prescribe legal in Massachusetts?", a: "Yes. The medications are prescribed by Massachusetts-licensed physicians and compounded by FDA-registered 503A pharmacies operating under strict USP guidelines. Massachusetts law fully permits the dispensing and delivery of these compounded medications." }
        ]}
      />

      <StateLegalFramework
        stateName="Massachusetts"
        boardName="Massachusetts Board of Registration in Medicine"
        text="Telehealth FX operates in strict compliance with the <strong>Massachusetts Board of Registration in Medicine (BORIM)</strong> and Massachusetts General Laws Chapter 112. Massachusetts law allows for the establishment of a physician-patient relationship via telehealth, including asynchronous store-and-forward technologies, when the standard of care is met. Telehealth was permanently expanded in the Commonwealth through legislation signed in 2021. All Telehealth FX prescribers treating Massachusetts patients hold active, unrestricted licenses verified through the BORIM Physician Profile system."
      />

      <DeliveryGridMap
        cityName="Boston"
        mapQuery="Boston, MA"
        coordinates="42.3601° N, 71.0589° W"
        counties="Suffolk County, Middlesex County, Norfolk County, Essex County"
        neighborhoods={['Back Bay', 'South End', 'Seaport', 'Cambridge', 'Somerville', 'Brookline', 'Newton', 'Waltham', 'Quincy', 'Dorchester']}
      />

      <FinalCTA stateName="Massachusetts" />

    
{/* Disclaimer: Mounjaro®, Zepbound®, Ozempic®, and Wegovy® are registered trademarks of their respective owners (Eli Lilly and Company and Novo Nordisk A/S). Telehealth FX is not affiliated with, endorsed by, or connected to any of these companies. Compounded medications are not FDA-approved and are not therapeutically equivalent to any branded product. */}
</div>
  );
}
